Aes 2024 Epilepsy Treatment. More than 5,000 of the world’s leading epilepsy professionals will join aes to learn about the most recent clinical and basic research, technology and treatment. Drug) announces the key opinion leader (kol).
In adults with convulsive status epilepticus, intramuscular midazolam, intravenous lorazepam, intravenous diazepam and intravenous phenobarbital are established as. More than 5,000 of the world’s leading epilepsy professionals will join aes to learn about the most recent.